期刊文献+

Bax介导硼替佐米诱导胃癌细胞株MKN45凋亡作用的研究 被引量:3

Bortezomib induced apoptosis of MNK45 cells through up-regulation of Bax
下载PDF
导出
摘要 目的验证BCl-2相关X(Bax)蛋白在硼替佐米(BTZ)诱导胃癌细胞株MKN45的凋亡作用。方法以人Bax(NC_000019.10)为靶标设计sh RNA序列,将Bax sh RNA转染至MKN45细胞中,G418筛选耐药克隆。荧光定量聚合酶链反应和Western blot测定转染前后Bax m RNA和蛋白含量。给予空载体对照MKN45及sh Bax转染的MKN45细胞BTZ梯度加药(5、25、50、100、250、500和1 000 nmol/L),检测其细胞增殖、凋亡程度。结果通过转染,建立Bax表达稳定下调的MKN45-sh Bax细胞系。给予BTZ梯度加药后,阴性对照(Mock)组胃癌细胞MKN45 Bax含量增加,凋亡程度逐渐增加,增殖率逐渐降低。沉默Bax后BTZ诱导的MKN45细胞凋亡受到抑制,增殖能力增强。结论 Bax能部分介导BTZ对胃癌细胞株MKN45的凋亡作用。 Objective To investigate the effect of Bax on Bortezomib-induced apoptosis of gastric cancer MNK45 cells. Methods Bax shRNA was constructed and transfected into MKN45 ceils. Bortezomib of gradient concentrations was administrated into MKN45 ceils (5 nmol/L, 25 nmol/L, 50 nmol/L, 100 nmol/L, 250 nmol/L, 500 nmol/L and 1,000 nmol/L). Cell viability and apoptosis rate were examined. Results Bax-knockdown MKN45 cell line was constructed by transfection. Gradient Bortezomib suppressed the proliferation of mock MKN45 cells and induced cell apoptosis, meanwhile Bax protein level was increased. Bortezomib increased apoptosis rate at a concentration of 500 nmol/L. In the shBax group, apoptosis rate was down-regulated and proliferation ability was strengthened. Conclusions Bax-mediated apoptosis caused by Bortezomib and knockdown of Bax could partially attenuate cell death caused by Bortezomib.
出处 《中国现代医学杂志》 CAS 北大核心 2017年第1期11-15,共5页 China Journal of Modern Medicine
基金 国家自然科学基金(N0:81472806)
关键词 胃癌 硼替佐米 BCl-2相关X 凋亡 gastric cancer Bortezomib Bax apoptosis
  • 相关文献

参考文献1

二级参考文献21

  • 1Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 1972,26(4) :239-257.
  • 2Evan GI, Vousden KH. Proliferation, cell cycle and apoptosis in cancer. Nature, 2001, 411 (6835) :342-348.
  • 3Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer, 2005, 5 (3) :231-237.
  • 4Denicourt C, Dowdy SF. Medicine. Targeting apoptotic pathways in cancer cells. Science, 2004, 305 (5689) : 1411-1413.
  • 5Meiler J, Schuler M. Therapeutic targeting of apoptotic pathways in cancer. Curr Drug Targets, 2006, 7(10) :1361-1369.
  • 6Ziegler DS, Kung AL. Therapeutic targeting of apoptosis pathways in cancer. Carr Opin Oncol, 2008, 20( 1 ) :97-103.
  • 7Marx J. Oncology. Recruiting the cell's own guardian for cancer therapy. Science, 2007, 315(5816):1211-1213.
  • 8Fesik SW. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer, 2005, 5 (11) :876-885.
  • 9Bremer E, van Dam G, Kroesen B J, et al. Targeted induction of apoptosis for cancer therapy: current progress and prospects. Trends M ol Med, 2006:12(8) :382-393.
  • 10Ghobrial IM, Witzig TE, Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin, 2005, 55 (3) :178-194.

共引文献1

同被引文献22

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部